Drug Type Small molecule drug |
Synonyms- |
Action agonists, inhibitors, antagonists |
Mechanism DRDs agonists(Dopamine receptors agonists), IMPDH inhibitors(Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitors), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) + [2] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC8H12N4O5 |
InChIKeyIWUCXVSUMQZMFG-AFCXAGJDSA-N |
CAS Registry36791-04-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Influenza, Human | Phase 2 | Canada | 01 Sep 2009 | |
Influenza, Human | Phase 2 | Singapore | 01 Sep 2009 | |
Influenza, Human | Phase 2 | Australia | 01 Sep 2009 | |
Influenza, Human | Phase 2 | Netherlands | 01 Sep 2009 | |
Influenza, Human | Phase 2 | United States | 01 Sep 2009 |